Updated:
Cirtec Medical Corp.
Cirtec provides end-to-end design and manufacturing for medical devices. Our integrated approach accelerates innovation, ensures quality, and reduces risk for...
Cirtec Medical Corp.
Cirtec provides end-to-end design and manufacturing for medical devices. Our integrated approach accelerates innovation, ensures quality, and reduces risk for Class II/III devices.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Brooklyn Park
Corporate office
Brooklyn Park, MN, United States
Principals
Steven Chevillotte
Member of the Board of Directors
Sector focus
Frequently asked questions
Who runs investment decisions at Cirtec Medical?
Cirtec Medical is a contract manufacturer, not an investment firm. Its strategic direction is set by the board of directors, which recently added Steven Chevillotte (per the firm, 2025). No CEO or CIO is publicly named.
Is Cirtec Medical structured as a family office or an operating company?
Cirtec Medical is an operating company — specifically a contract development and manufacturing organization (CDMO) serving medical device firms. It does not present itself as a family office or asset manager.
What investment stages does Cirtec Medical typically target?
Cirtec does not invest in external companies. It provides design, development, and manufacturing services for medical devices across all stages from concept to market.
Which sectors does Cirtec Medical explicitly avoid?
The firm does not publicly disclose any explicitly avoided sectors. Its focus is medical devices, especially Class II and III products.
Does Cirtec Medical participate in fund commitments or only direct deals?
Cirtec Medical does not participate in fund commitments or direct deals as an investment entity. It operates solely as a service provider.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: